Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Abl Bio Inc. manages a company patent portfolio that currently includes 2 pending office actions. These actions are being reviewed by 2 distinct examiners. The data shows that there are 0 distinct art units recorded for these matters, which represents the current administrative state of the portfolio's pending applications.
The busiest examiner for this portfolio is GURLEY, JAMI MICHELLE, who is currently handling 1 pending office action. With 2 pending office actions total across 2 distinct examiners, the workload is divided equally. Each examiner is responsible for exactly 1 of the current pending actions. This structure indicates a distributed prosecution effort where no examiner dominates the current pending workload. The presence of 2 distinct examiners suggests that the company is engaging with multiple perspectives within the patent office even as the art unit data remains at 0. For a practitioner, this means coordinating with 2 different examiners for the company's 2 pending actions without a recorded art unit classification. This distribution requires managing 2 separate examiner relationships simultaneously.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GURLEY, JAMI MICHELLE | 1 | 53.3% | +16.1% |
| GODDARD, LAURA B | 1 | 50.9% | +13.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684660 | Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof | GURLEY, JAMI MICHELLE | — |
| 18580552 | ANTI-CLL-1 ANTIBODIES AND USES THEREOF | GODDARD, LAURA B | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684660 | Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof | GURLEY, JAMI MICHELLE | — | §112 | Non-Final OA | — | Pending | Feb 17, 2024 |
| 18580552 | ANTI-CLL-1 ANTIBODIES AND USES THEREOF | GODDARD, LAURA B | — | §112 | Non-Final OA | — | Pending | Jan 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial